AdV-tk
BrTK01
Phase 1 mab completed
Quick answer
AdV-tk for Malignant Glioma is a Phase 1 program (mab) at Candel Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Candel Therapeutics
- Indication
- Malignant Glioma
- Phase
- Phase 1
- Modality
- mab
- Status
- completed